Pacira | PCRX - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Astellas Pharma JPY 199.75B 17.8B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Coherus Biosciences USD 9.91M 14.98M 2025-12
Heron Therapeutics USD 8.97M 24K 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
J&J USD 10.46B 1.53B 2026-03
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novo Nordisk DKK 14.8B 4.96B 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 434.8M 39.7M 2026-03
Pfizer USD 4.51B 734M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03
Xoma USD 2.65M 1.52M 2025-09
Zoetis USD 507M 20M 2026-03